BioSpace News Archive

Wearable Health Solutions, Inc., is pleased to announce that it is participating in, and has begun to ship product to a pilot program, with the Government of Bermuda, which will sell it’s iHelp Devices through a local dealer network to further grow it’s business in the country.

StageZero Life Sciences announced that it will release its First Quarter 2021operational results before market open on Monday, May 17, 2021.

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the first quarter ended March 31, 2021.

Alpine Orthopaedic & Spine announces they have begun the process of looking for a new location to expand its facility and services, and is actively recruiting additional surgeons.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for oral, once-daily ORLADEYO™ (berotralstat) for the routine prevention of recurrent hereditary angioedema (HAE) attacks in HAE patients 12 years and older.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s Linea™ COVID-19 Assay Kit (the “Assay Kit”)

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today disclosed the first efficacy and safety data from a small cohort of patients in its ongoing Phase 1b clinical trial of its lead candidate mavorixafor

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and vision applications, today announced that it has been selected as the ‘Best Overall Medical Device Company’ in the MedTech Breakthrough Awards.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced that mitapivat clinical data will be presented at the European Hematology Association (EHA) Annual Congress being held virtually June 9-17, 2021.

CYduct Diagnostics, Inc. is pleased to announce it has signed and closed an agreement to acquire all the assets of HHC PREFERRED LLC.